Loop-dx was born in Barcelona during the 2017 D-Health Moebio program. We began with the goal of “saving lives through faster treatment”. In a disease like Sepsis, fast diagnostics is key to preventing mortality, yet current solutions are often unable to detect the presence of this deadly condition in asymptomatic patients.
Loop-dx is committed to developing state of the art, point-of-care diagnostics for faster detection of Sepsis and similar life-threatening infectious conditions. Our goal is to reduce sepsis mortality, patient side effects, and antibiotic resistence; giving healthcare provides the tools they need to save lives and reducing time and costs for treatment.